Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beckman Coulter, Inc.
Beckman Coulter, Inc. Announces Common Stock Offering
June 7th, 2009
Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced it has commenced a public offering of shares of its common stock, to finance in part the previously announced acquisition of the diagnostic systems portion of Olympus Corporation's Life Science business, or the acquisition. The Company expects to raise proceeds of approximately $235 million in the offering, or $250 million if the over-allotment option granted to the underwriters is exercised in full. Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering....
Source: Pharma Investments, Ventures & Law Weekly (2009-06-07)
|
